Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases
Launched by ISTITUTO AUXOLOGICO ITALIANO · Mar 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding motor neuron diseases (MND), including conditions like Amyotrophic Lateral Sclerosis (ALS). Researchers want to learn more about the different ways MND can show up in patients, known as "clinical phenotypes." By gathering this information, the study hopes to improve our understanding of the disease and help doctors predict how it might progress in different patients.
If you're between the ages of 65 and 74 and have been diagnosed with ALS or another motor neuron disease, you may be eligible to participate. Those who join the study will undergo several evaluations, including tests to assess their physical and mental health, as well as some additional tests to analyze genetic information. It's important to note that participation is entirely voluntary, and anyone who does not wish to take part will not be included in the study. This research could provide valuable insights into motor neuron diseases, helping improve care and treatment for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of ALS or other motor neuron disease
- Exclusion Criteria:
- • refusal to participate to the study
About Istituto Auxologico Italiano
Istituto Auxologico Italiano is a prominent Italian research institute dedicated to advancing medical science and improving patient care through innovative clinical research. With a strong focus on metabolic diseases, cardiovascular health, and neuropsychological disorders, the institute integrates clinical practice with cutting-edge research to foster the development of new therapeutic strategies. Committed to ethical standards and patient safety, Istituto Auxologico Italiano collaborates with various national and international partners, contributing significantly to the global medical community while ensuring high-quality care and support for its patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milano, Mi, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported